Research grant for early career investigators announced.
Research grant for early career investigators announced.

New Website Offers More Info

Be among the first visitors to our newly expanded and improved website. You'll find:
The internet serves as a vital resource for individuals with NETs and their families. We've worked to expand the topics and content we offer on and make the site easier to use. You'll find a wider range of topics to explore, including nutrition, emotions, and a new patient stories section. Please take a moment to explore all the site has to offer and send us your comments at

Introducing NETRF Mentored Research Award 

Essential Funding for Early Career Investigators

NETRF is pleased to announce a new two-year Mentored Award for researchers currently in post-doctoral, fellowship, or residency positions. Made possible by a grant from IPSEN, this award is designed to support early career investigators to launch a career in neuroendocrine cancer research. (MORE)

Grant Funds Exploration of Precision  Tool to Prevent Metastasis 

With a new ERF/NETRF collaborative research grant, Tara Mastren, PhD, University of Utah, will explore a targeted alpha treatment (TAT) for NETs to eliminate lingering cancer cells with radiation to head off metastasis. This nanoparticle system could help scientists develop a needed tool to reduce the recurrence and spread of neuroendocrine tumors. (MORE)

The Power of Persistence

Following a series of cancer research conferences this spring where she heard Nobel Prize winner James Allison, PhD, look back on his discoveries, NETRF CEO Elyse Gellerman blogs about the importance of taking risks, believing in yourself, and having faith in the scientific process of basic research. (MORE)
Get Involved

Dr. Mark Lewis Joins NETRF Board

Mark Lewis, MD, has joined the NETRF Board of Directors. He is Director of GI Oncology at Intermountain Healthcare, Utah. Dr. Lewis has a specialized interest in inherited risks and syndromes that contribute to early-onset cancers. His commitment to neuroendocrine cancer goes beyond a professional interest. Learn about his compelling personal reasons for getting involved with the search for a cure. (MORE) 

Dr. Anil Rustgi Joins Columbia University

NETRF Scientific Advisor Anil Rustgi, MD, started a new post in April as Director of Herbert Irving Comprehensive Cancer Center at Columbia University. Rustgi was at Penn Medicine for 20 years, most recently as Chief of Gastrointestinal Cancers. Rustgi is one of ten leading clinical and scientific experts on NETRF's Board of Scientific Advisors.    

Doctors Day 2019

Patients and Families Honor Providers 

Learn how thankful patients and families have sent a message of thanks to their care providers with a gift to advance our knowledge of neuroendocrine cancer. Making a tribute gift in the name of a physician expresses gratitude in addition to signaling your hope for improvements in the treatment of NETs. (MORE).

NETRF Earns High Marks 

A leading nonprofit ranking program, designed to inform donor decision-making, has again given the NeuroendocrineTumor Research Foundation its highest award for fiscal responsibility and transparency.  (MORE)

Family Fun Day

A Roxboro, NC, family fun day is planned on Saturday, May 18, 10 am - 2 pm, at the Concord United Methodist Church in Roxboro, NC. Hoops, face painting, crafts, and music will surround a hotdog lunch to raise money in support of NETRF. (MORE)
Education & Advocacy

Are You Having Surgery?

You Can Help NET Research

You can help advance neuroendocrine tumor research by donating tumor tissue. By contributing your tumor tissue through a surgery, biopsy, or fluid drain you make it possible for researchers to make a working copy of your cancer type that will continually grow in a laboratory. This copy is called a "model" and it makes it easy for researchers to study your cancer type and test treatment ideas. Through a unique collaboration with, we are working to make it easier than ever for you to help fuel research. (MORE)

Nutrition for Symptom Management

Eating with NETs

Learn what foods help reduce symptoms associated with neuroendocrine cancer and related syndromes. What and when you eat or drink can affect how you feel. Find greater relief and freedom with these nutritional modifications. (MORE)

2019 LACNETS Conference

Saturday, June 8, Los Angeles 

The 2019 LACNETS conference will include several presentations on PRRT as well as Gallium-68 dotatate scans, carcinoid syndrome, surgery, liver-directed therapy,  pathology, and clinical trials. Learn from the physician panel as they discuss NET case studies to show how they make treatment sequencing decisions. 
This conference also allows patients and caregivers to connect with other NET patients and caregivers. It provides a rare opportunity to speak with physicians through Q&A sessions and roundtable discussions. NETRF is proud to continue its support of the annual LACNETS conference. (MORE)
Doctor Database   Patient Groups
Newly Diagnosed   About NETs
Facebook Twitter
Contact Us

NET Research Foundation
321 Columbus Avenue, Suite 5R
Boston, MA 02116

(617) 946-1780 |
The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers.

NETRF is a 501(c)(3) organization. All contributions are tax-deductible to the extent allowed by law. To learn more,
view our Audited Financial Statements and IRS Form 990.
powered by emma
Subscribe to our email list.